Source: Annual Congress 2009 - Models of chronic airways disease and therapy
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
I. Belyanin, E. Shmelev (Moscow, Russian Federation). Changes in susceptibility to antibiotics staphylococcus aureus under effect of dissolved ozone. Eur Respir J 2009; 34: Suppl. 53, 2062

Member's Comments

No comment yet.

Related content which might interest you: Staphylococcus aureus sensitivity changes to antibiotics under the influence of dissolved ozone Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011 Pseudomonas aerugenosa sensitivity changes to antibiotics under the influence of dissolved ozone Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011 Mechanisms of acquisition of resistance in Staphylococcus aureus Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? Year: 2006 Staphlococcus aureus: susceptibility to antibacterial drugs and rate of MRSA Source: Eur Respir J 2006; 28: Suppl. 50, 788s Year: 2006 Exposure to sub-lethal levels of penicillin G and high osmotic potential leads to stable antibiotic resistance in Staphylococcus aureus Source: Eur Respir J 2002; 20: Suppl. 38, 421s Year: 2002 Treatment challenges in methicillin resistant Staphylococcus aureus infections Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? Year: 2006 Effects of subinhibitory concentrations of antibiotics on the biofilm formation of pseudomonas aeruginosa Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011 Evolution of tetracycline resistant S. aureus in hypoxia Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 The efficacies of macrolides in a murine model of methicillin-resistant staphylococcus aureus hematogenous pulmonary infection Source: Eur Respir J 2002; 20: Suppl. 38, 357s Year: 2002 Molecular epidemiology and antimicrobial resistance of methicillin-resistant staphylococcus aureus isolated from nasal swab at intensive care unit Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens Year: 2008 Long-term, low-dose azithromycin treatment reduces the prevalence of staphylococcus aureus, but selects for macrolide resistance in Danish CF-patients Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects Year: 2007 Synergistic activity of colistin in combination with N-acetylcysteine against colistin-resistant Acinetobacter Baumannii grown in biofilms Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 Cell wall deficiency: a novel mechanism for methicillin resistance in Staphylococcus aureus Source: Eur Respir J 2005; 26: Suppl. 49, 94s Year: 2005 Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae Source: Eur Respir J 2006; 27: 1020-1025 Year: 2006 Antibiotic susceptibility patterns of respiratory strains of Staphylococcus aureus in a Turkish university hospital Source: Eur Respir J 2003; 22: Suppl. 45, 148s Year: 2003 What is MRSA? Source: Eur Respir J 2009; 34: 1190-1196 Year: 2009 The antimicrobial molecule elafin protects the lung against Staphylococcus aureus infection Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence Year: 2004 Predictive factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a MRSA screening protocol. Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Clinical outcomes of patients with hospital-acquired pneumonia due to community-associated methicillin resistant staphylococcus aureus (CA-MRSA) Source: Eur Respir J 2007; 30: Suppl. 51, 407s Year: 2007